BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 15853896)

  • 1. Selective monomorphic and polymorphic HLA class I antigenic determinant loss in surgically removed melanoma lesions.
    Kageshita T; Ishihara T; Campoli M; Ferrone S
    Tissue Antigens; 2005 May; 65(5):419-28. PubMed ID: 15853896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ganglioside, adhesion molecule, and HLA antigen expression in basal cell carcinoma lesions.
    Kageshita T; Ono T; Hirai S; Yoshii A; Kimura T; Nakakuma H; Horikawa K; Takatsuki K; Ferrone S
    Cancer Res; 1992 Jun; 52(11):3201-7. PubMed ID: 1350511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surface antigenic profile of uveal melanoma lesions analysed with a panel of monoclonal antibodies directed against cutaneous melanoma.
    Carrel S; Schreyer M; Gross N; Zografos L
    Anticancer Res; 1990; 10(1):81-9. PubMed ID: 1692197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of HLA-A,B,C antigens on primary and metastatic tumor cell populations of human carcinomas.
    Cordon-Cardo C; Fuks Z; Drobnjak M; Moreno C; Eisenbach L; Feldman M
    Cancer Res; 1991 Dec; 51(23 Pt 1):6372-80. PubMed ID: 1933900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential expression of melanoma associated antigens in acral lentiginous melanoma and in nodular melanoma lesions.
    Kageshita T; Nakamura T; Yamada M; Kuriya N; Arao T; Ferrone S
    Cancer Res; 1991 Mar; 51(6):1726-32. PubMed ID: 1671829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of surface HLA-A,B,C molecules in tumour immunity.
    Möller P; Hämmerling GJ
    Cancer Surv; 1992; 13():101-27. PubMed ID: 1423320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential expression of intercellular adhesion molecule 1 in primary and metastatic melanoma lesions.
    Natali P; Nicotra MR; Cavaliere R; Bigotti A; Romano G; Temponi M; Ferrone S
    Cancer Res; 1990 Feb; 50(4):1271-8. PubMed ID: 1967552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Study of monomorphic determinants on DR molecules of HLA class II antigens.
    Poláková K; Karpatová M
    Neoplasma; 1990; 37(3):239-51. PubMed ID: 1695326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The differential reactivity of cells of the melanocytic lineage with four monoclonal antibodies against IFN-gamma inducible molecules.
    Vacca A; Frassanito A; Rimoldi D; Dammacco F; Carrel S
    Anticancer Res; 1992; 12(1):1-9. PubMed ID: 1348919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sialyl-dimeric Lewis-X antigen expressed on mucin-like glycoproteins in colorectal cancer metastases.
    Matsushita Y; Cleary KR; Ota DM; Hoff SD; Irimura T
    Lab Invest; 1990 Dec; 63(6):780-91. PubMed ID: 1979361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MHC antigens in human melanomas.
    Ruiter DJ; Mattijssen V; Broecker EB; Ferrone S
    Semin Cancer Biol; 1991 Feb; 2(1):35-45. PubMed ID: 1912517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Expression of HLA-class II antigens in malignant melanoma].
    Nakamura T; Matsuno M; Kageshita T; Arao T
    Nihon Hifuka Gakkai Zasshi; 1990 Jan; 100(1):49-56. PubMed ID: 2191157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for the expression of non-HLA-A,-B,-C class I genes in the human fetal liver.
    Houlihan JM; Biro PA; Fergar-Payne A; Simpson KL; Holmes CH
    J Immunol; 1992 Jul; 149(2):668-75. PubMed ID: 1624808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of the colorectal carcinoma-associated antigen defined by monoclonal antibody D612.
    Fernsten PD; Primus FJ; Greiner JW; Simpson JF; Schlom J
    Cancer Res; 1991 Feb; 51(3):926-34. PubMed ID: 1988133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [MHC class I antigen expression by molar trophoblast].
    Sasagawa M; Yamada K; Fujita K; Shiota A; Sasaki T; Hirokawa M; Yamazaki T; Kurose T; Ohno M; Hando T
    Nihon Sanka Fujinka Gakkai Zasshi; 1990 Oct; 42(10):1277-83. PubMed ID: 2230405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Immunologic modulation of tumor aggressiveness in cancer of the larynx. II. Clinicopathologic correlations with the loss of expression of the HLA ABC antigens].
    Esteban F; Concha A; Delgado M; Ruiz-Cabello F; Garrido F
    Acta Otorrinolaringol Esp; 1990; 41(6):359-68. PubMed ID: 2092725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The expression of leukocytic and related antigens on the cells of human breast cancer cells].
    Tupitsyn NN; Kadagidze ZG; Blokhina NG; Baryshnikov AIu; Ermilova VD; Artamonova EV; Moldenhauer G; Bernard A
    Eksp Onkol; 1990; 12(2):54-8. PubMed ID: 1690634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Immunologic modulation of tumor aggressiveness in cancer of the larynx. I. Genetic and molecular studies of HLA class I antigens].
    Esteban F; Concha A; Ruiz-Cabello F; Garrido F
    Acta Otorrinolaringol Esp; 1990; 41(5):297-303. PubMed ID: 2076309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of polymorphic HLA-A,B epitopes in human urothelial cell lines.
    Ottesen SS; Kieler J
    Anticancer Res; 1991; 11(1):217-23. PubMed ID: 1708220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An immunohistochemical and prognostic analysis of cytokeratin expression in malignant uveal melanoma.
    Fuchs U; Kivelä T; Summanen P; Immonen I; Tarkkanen A
    Am J Pathol; 1992 Jul; 141(1):169-81. PubMed ID: 1378696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.